Skip to main content
SpringerLink
Log in

Treatment of Porokeratosis: A Systematic Review

  • Systematic Review
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Background

Porokeratosis (PK) is a rare skin disease of unknown etiology. It consists of a keratinization disorder, which may appear in several clinical forms and can undergo malignant transformation. The histopathological hallmark of PK is the cornoid lamella. While many topical, systemic, and surgical treatment modalities for PK have been described, no randomized controlled trials have been performed yet. Because of a lack of treatment standards for PK, European and international guidelines cannot be created.

Objective

The aim of this systematic review is to outline options for treating PK.

Methods

We performed a systematic literature search in an electronic database for published literature. A total of 88 articles fulfilling our inclusion criteria were found.

Results

There were no randomized controlled trials on the treatment of PK, but mainly case reports and case series. Porokeratosis of Mibelli showed the best outcomes after treatment with imiquimod cream and linear PK responded well to topical or systemic retinoids. Topical vitamin D acid derivatives may be the best therapeutic option for disseminated PK. Surgical interventions and cryotherapy may be preferred in areas where the use of topical agents is difficult or contraindicated.

Conclusion

To offer patients with PK an evidence-based high-quality standardized therapy, randomized controlled trials are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Allegra F. The man behind the eponym. Vittorio Mibelli and the tale of “porokeratosis”. Am J Dermatopathol. 1986;8(2):169–72.

    Article  CAS  PubMed  Google Scholar 

  2. Levitt JO, Keeley BR, Phelps RG. Treatment of porokeratosis of Mibelli with cantharidin. J Am Acad Dermatol. 2013;69(5):e254–5. doi:10.1016/j.jaad.2013.06.021.

    Article  PubMed  Google Scholar 

  3. Kanitakis J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur J Dermatol. 2014;24(5):533–44. doi:10.1684/ejd.2014.2402.

    CAS  PubMed  Google Scholar 

  4. Sertznig P, von Felbert V, Megahed M. Porokeratosis: present concepts. J Eur Acad Dermatol Venereol. 2012;26(4):404–12. doi:10.1111/j.1468-3083.2011.04275.x.

    Article  CAS  PubMed  Google Scholar 

  5. Wade TR, Ackerman AB. Cornoid lamellation: a histologic reaction pattern. Am J Dermatopathol. 1980;2(1):5–15.

    Article  CAS  PubMed  Google Scholar 

  6. Sasson M, Krain AD. Porokeratosis and cutaneous malignancy: a review. Dermatol Surg. 1996;22(4):339–42.

    Article  CAS  PubMed  Google Scholar 

  7. Lederman JS, Sober AJ, Lederman GS. Immunosuppression: a cause of porokeratosis? J Am Acad Dermatol. 1985;13(1):75–9.

    Article  CAS  PubMed  Google Scholar 

  8. Vire G, Latour D, King LE Jr. Porokeratosis and immunosuppression. J Am Acad Dermatol. 1986;14(4):683–4.

    Article  CAS  PubMed  Google Scholar 

  9. Kanitakis J, Euvrard S, Faure M, Claudy A. Porokeratosis and immunosuppression. Eur J Dermatol. 1998;8(7):459–65.

    CAS  PubMed  Google Scholar 

  10. Zhang SQ, Jiang T, Li M, et al. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nat Genet. 2012;44(10):1156–60. doi:10.1038/ng.2409.

    Article  CAS  PubMed  Google Scholar 

  11. Zhou Y, Liu J, Fu X, et al. Identification of three novel frameshift mutations of the MVK gene in four Chinese families with disseminated superficial actinic porokeratosis. Br J Dermatol. 2013;169(1):193–5. doi:10.1111/bjd.12224.

    Article  CAS  PubMed  Google Scholar 

  12. Neumann RA, Knobler RM, Jurecka W, Gebhart W. Disseminated superficial actinic porokeratosis: experimental induction and exacerbation of skin lesions. J Am Acad Dermatol. 1989;21(6):1182–8.

    Article  CAS  PubMed  Google Scholar 

  13. Kawara S, Oiso N, Kawada A. Disseminated superficial actinic porokeratosis in a patient undergoing treatment with long-term narrowband ultraviolet B for psoriasis. J Dermatol. 2011;38(6):585–7. doi:10.1111/j.1346-8138.2010.01099.x.

    Article  PubMed  Google Scholar 

  14. Parish JL. Topical vitamin D3 analogues: unapproved uses, dosages, or indications. Clin Dermatol. 2002;20(5):558–62.

    Article  PubMed  Google Scholar 

  15. Nakamura Y, Yamaguchi M, Nakamura A, Muto M. Calcipotriol and adapalene therapy for disseminated superficial actinic porokeratosis. Indian J Dermatol Venereol Leprol. 2014;80(4):373–4. doi:10.4103/0378-6323.136981.

    Article  PubMed  Google Scholar 

  16. Noborio R, Morita A. Split-face trial of CO(2) laser-induced ring abrasion and high-dose tacalcitol in the treatment of disseminated superficial actinic porokeratosis. J Dermatol. 2012;39(10):879–80. doi:10.1111/j.1346-8138.2011.01461.x.

    Article  PubMed  Google Scholar 

  17. Abe M, Yokoyama Y, Ishikawa O. Successful treatment of disseminated superficial actinic porokeratosis with tacalcitol lotion. J Dermatol. 2010;37(10):913–5. doi:10.1111/j.1346-8138.2010.00902.x.

    Article  PubMed  Google Scholar 

  18. Asawanonda P, Noppakun N, Huiprasert P. Seborrheic keratosis-like porokeratosis: a case report. Dermatol Online J. 2005;11(1):18.

    PubMed  Google Scholar 

  19. Bohm M, Luger TA, Bonsmann G. Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol. J Am Acad Dermatol. 1999;40(3):479–80.

    Article  CAS  PubMed  Google Scholar 

  20. Harrison PV, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol. 1994;19(1):95.

    Article  CAS  PubMed  Google Scholar 

  21. Tchernev G, Chokoeva AA, Ivanova B, et al. Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel? Wien Med Wochenschr. 2016;. doi:10.1007/s10354-016-0484-8 (Epub ahead of print).

    Google Scholar 

  22. Bakardzhiev I, Kavaklieva S, Pehlivanov G. Successful treatment of disseminated superficial actinic porokeratosis with calcipotriol. Int J Dermatol. 2012;51(9):1139–42. doi:10.1111/j.1365-4632.2010.04704.x.

    Article  PubMed  Google Scholar 

  23. Kohara Y, Takeo T, Oshima Y, et al. Linear porokeratosis with nail dystrophy. Eur J Dermatol. 2011;21(4):625–6. doi:10.1684/ejd.2011.1393.

    PubMed  Google Scholar 

  24. Fritsch PO. Retinoids in psoriasis and disorders of keratinization. J Am Acad Dermatol. 1992;27(6 Pt 2):S8–14.

    Article  CAS  PubMed  Google Scholar 

  25. Garg T, Ramchander Varghese B, et al. Generalized linear porokeratosis: a rare entity with excellent response to acitretin. Dermatol Online J. 2011;17(5):3.

    PubMed  Google Scholar 

  26. Hong JB, Hsiao CH, Chu CY. Systematized linear porokeratosis: a rare variant of diffuse porokeratosis with good response to systemic acitretin. J Am Acad Dermatol. 2009;60(4):713–5. doi:10.1016/j.jaad.2008.10.011.

    Article  PubMed  Google Scholar 

  27. Dervis E, Demirkesen C. Generalized linear porokeratosis. Int J Dermatol. 2006;45(9):1077–9. doi:10.1111/j.1365-4632.2004.02490.x.

    Article  PubMed  Google Scholar 

  28. Grover C, Goel A, Nanda S, et al. A case of extensive linear porokeratosis with evaluation of topical tretinoin versus 5-flourouracil as treatment modalities. J Dermatol. 2005;32(12):1000–4.

    Article  PubMed  Google Scholar 

  29. Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dermatol. 1995;131(4):496–7.

    Article  CAS  PubMed  Google Scholar 

  30. Borroni RG, Poddighe D, Zecca M, Brazzelli V. Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease. Pediatr Dermatol. 2013;30(1):148–50. doi:10.1111/j.1525-1470.2011.01610.x.

    Article  PubMed  Google Scholar 

  31. Uuskula A, Erm T. Disseminated giant hyperkeratotic porokeratosis and treatment with acitretin: a case report. Acta Derm Venereol. 2015;95(2):241–2. doi:10.2340/00015555-1908.

    Article  PubMed  Google Scholar 

  32. Hartman R, Mandal R, Sanchez M, Stein JA. Porokeratosis plantaris, palmaris, et disseminata. Dermatol Online J. 2010;16(11):22.

    PubMed  Google Scholar 

  33. Skroza N, Proietti I, Bernardini N, et al. Acitretin for treatment of familial porokeratosis palmaris et plantaris disseminate. Eur J Dermatol. 2012;22(5):699–700. doi:10.1684/ejd.2012.1826.

    PubMed  Google Scholar 

  34. Kumar SS, Lee S. Genitogluteal porokeratosis: an unusual clinical presentation. Aust J Dermatol. 2012;53(2):e36–9. doi:10.1111/j.1440-0960.2011.00784.x.

    Article  Google Scholar 

  35. Tallon B, Blumental G, Bhawan J. Porokeratosis ptychotropica: a lesser-known variant. Clin Exp Dermatol. 2009;34(8):e895–7. doi:10.1111/j.1365-2230.2009.03664.x.

    Article  CAS  PubMed  Google Scholar 

  36. Uenishi T, Teramura K, Kitamura M, et al. Hyperkeratotic variant of porokeratosis Mibelli with dermal amyloid deposits. J Dermatol. 2010;37(5):475–9. doi:10.1111/j.1346-8138.2010.00803.x.

    Article  PubMed  Google Scholar 

  37. Gotz A, Kopera D, Wach F, et al. Porokeratosis Mibelli gigantea: case report and literature review]. [Article in German. Hautarzt. 1999;50(6):435–8.

    Article  CAS  PubMed  Google Scholar 

  38. Agrawal SK, Gandhi V, Madan V, Bhattacharya SN. Topical tretinoin in Indian male with zosteriform porokeratosis. Int J Dermatol. 2003;42(11):919–20.

    Article  PubMed  Google Scholar 

  39. Gutierrez EL, Galarza C, Ramos W, et al. Facial porokeratosis: a series of six patients. Aust J Dermatol. 2010;51(3):191–4. doi:10.1111/j.1440-0960.2009.00616.x.

    Article  Google Scholar 

  40. Suarez-Amor O, Pereiro-Ferreiros M, Ginarte M, et al. Coexistence of linear porokeratosis and disseminated superficial actinic porokeratosis: a type 2 segmental manifestation. Acta Derm Venereol. 2007;87(4):363–4. doi:10.2340/00015555-0215.

    Article  PubMed  Google Scholar 

  41. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43(1 Pt 2):S6–11.

    Article  CAS  PubMed  Google Scholar 

  42. Gajic B, Tang K, Whitfeld M. Porokeratosis of Mibelli: involution and resolution with 5% imiquimod cream. Aust J Dermatol. 2011;52(4):301–3. doi:10.1111/j.1440-0960.2010.00712.x.

    Article  Google Scholar 

  43. Esser AC, Pittelkow MR, Randle HW. Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream. Dermatol Surg. 2006;32(6):858–61. doi:10.1111/j.1524-4725.2006.32176.x.

    CAS  PubMed  Google Scholar 

  44. Jain S. Successful treatment of porokeratosis of Mibelli with imiquimod 5% cream. Clin Exp Dermatol. 2006;31(2):302–3. doi:10.1111/j.1365-2230.2005.02044.x.

    Article  CAS  PubMed  Google Scholar 

  45. Agarwal S, Berth-Jones J. Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream. Br J Dermatol. 2002;146(2):338–9.

    Article  CAS  PubMed  Google Scholar 

  46. Montes-De-Oca-Sanchez G, Tirado-Sanchez A, Garcia-Ramirez V. Porokeratosis of Mibelli of the axillae: treatment with topical imiquimod. J Dermatol Treat. 2006;17(5):319–20. doi:10.1080/09546630600944116.

    Article  Google Scholar 

  47. Gracia-Cazana T, Vera-Alvarez J, Garcia-Patos V, Gilaberte Y. Imiquimod and photodynamic therapy are useful in the treatment of porokeratosis in children with bone marrow transplantation. Pediatr Dermatol. 2015;32(6):e291–3. doi:10.1111/pde.12654.

    Article  PubMed  Google Scholar 

  48. Erbagci Z, Tuncel AA, Erbagci I. Successful treatment of porokeratosis with topical imiquimod in 2 immunosuppressed cases. J Drugs Dermatol. 2006;5(7):668–71.

    PubMed  Google Scholar 

  49. Arun B, Pearson J, Chalmers R. Disseminated superficial actinic porokeratosis treated effectively with topical imiquimod 5% cream. Clin Exp Dermatol. 2011;36(5):509–11. doi:10.1111/j.1365-2230.2011.04064.x.

    Article  CAS  PubMed  Google Scholar 

  50. Ahn SJ, Lee HJ, Chang SE, et al. Case of linear porokeratosis: successful treatment with topical 5% imiquimod cream. J Dermatol. 2007;34(2):146–7. doi:10.1111/j.1346-8138.2006.00236.x.

    Article  PubMed  Google Scholar 

  51. Kindem S, Serra-Guillen C, Sorni G, et al. Treatment of porokeratosis of Mibelli with ingenol mebutate: a possible new therapeutic option. JAMA Dermatol. 2015;151(1):85–6. doi:10.1001/jamadermatol.2014.2697.

    Article  PubMed  Google Scholar 

  52. Moore AY. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatol Treat. 2009;20(6):328–35. doi:10.3109/09546630902789326.

    Article  Google Scholar 

  53. Harrison S, Sinclair R. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream. Aust J Dermatol. 2003;44(4):281–3.

    Article  Google Scholar 

  54. Chowdhury MM, Inaloz HS, Holt PJ. A scaly macule on the bridge of the nose of a 15-year-old boy. Pediatr Dermatol. 2000;17(2):149–50.

    Article  CAS  PubMed  Google Scholar 

  55. Danby W. Treatment of porokeratosis with fluorouracil and salicylic acid under occlusion. Dermatol Online J. 2003;9(5):33.

    PubMed  Google Scholar 

  56. Venkatarajan S, LeLeux TM, Yang D, et al. Porokeratosis of Mibelli: successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatol Online J. 2010;16(12):10.

    PubMed  Google Scholar 

  57. Teixeira SP, de Nascimento MM, Bagatin E, et al. The use of fluor-hydroxy pulse peel in actinic porokeratosis. Dermatol Surg. 2005;31(9 Pt 1):1145–8.

    Article  CAS  PubMed  Google Scholar 

  58. Zhan H, Zheng H. The role of topical cyclo-oxygenase-2 inhibitors in skin cancer: treatment and prevention. Am J Clin Derm. 2007;8(4):195–200.

    Article  Google Scholar 

  59. Marks S, Varma R, Cantrell W, et al. Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol. 2009;23(1):42–5. doi:10.1111/j.1468-3083.2008.02943.x.

    Article  CAS  PubMed  Google Scholar 

  60. Kluger N, Dereure O, Guilhou JJ, Guillot B. Genital porokeratosis: treatment with diclofenac topical gel. J Dermatol Treat. 2007;18(3):188–90. doi:10.1080/09546630701258101.

    Article  CAS  Google Scholar 

  61. Vlachou C, Kanelleas AI, Martin-Clavijo A, Berth-Jones J. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series. J Eur Acad Dermatol Venereol. 2008;22(11):1343–5. doi:10.1111/j.1468-3083.2008.02842.x.

    Article  CAS  PubMed  Google Scholar 

  62. Tee SI, Chong WS. Eruptive pruritic papular porokeratosis. Indian J Dermatol Venereol Leprol. 2012;78(6):758–60. doi:10.4103/0378-6323.102384.

    Article  PubMed  Google Scholar 

  63. Verma KK, Singh OP. Dexamethasone pulse treatment in disseminated porokeratosis of Mibelli. J Dermatol Sci. 1994;7(1):71–2.

    Article  CAS  PubMed  Google Scholar 

  64. Klein N, Enk A, Hartschuh W. Inflammatory stage of disseminated superficial porokeratosis in a 71-year old patient]. [Article in German. Hautarzt. 2009;60(5):420–3. doi:10.1007/s00105-008-1639-3.

    Article  CAS  PubMed  Google Scholar 

  65. Chen TJ, Chou YC, Chen CH, et al. Genital porokeratosis: a series of 10 patients and review of the literature. Br J Dermatol. 2006;155(2):325–9. doi:10.1111/j.1365-2133.2006.07295.x.

    Article  PubMed  Google Scholar 

  66. Kim DS, Roh MR, Lee JH, Lee KH. Pterygium unguis formation in porokeratosis of Mibelli. Br J Dermatol. 2007;156(6):1384–5. doi:10.1111/j.1365-2133.2007.07887.x.

    Article  CAS  PubMed  Google Scholar 

  67. Simpson D, Noble S. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs. 2005;65(6):827–58.

    Article  CAS  PubMed  Google Scholar 

  68. Parks AC, Conner KJ, Armstrong CA. Long-term clearance of linear porokeratosis with tacrolimus, 01%, ointment. JAMA Dermatol. 2014;150(2):194–6. doi:10.1001/jamadermatol.2013.8526.

    Article  PubMed  Google Scholar 

  69. Rabbin PE, Baldwin HE. Treatment of porokeratosis of Mibelli with CO2 laser vaporization versus surgical excision with split-thickness skin graft: a comparison. J Dermatol Surg Oncol. 1993;19(3):199–202.

    Article  CAS  PubMed  Google Scholar 

  70. Merkle T, Hohenleutner U, Braun-Falco O, Landthaler M. Reticulate porokeratosis: successful treatment with CO2-laser vaporization. Clin Exp Dermatol. 1992;17(3):178–81.

    Article  CAS  PubMed  Google Scholar 

  71. Hernandez-Bel P, Sanmartin-Jimenez O, Sorni-Broker G, Guillen-Barona C. Labial porokeratosis. Am J Dermatopathol. 2010;32(6):638. doi:10.1097/DAD.0b013e3181caac93.

    Article  PubMed  Google Scholar 

  72. Kim HS, Baek JH, Park YM, et al. Photodynamic therapy combined with CO(2) laser vaporization on disseminated superficial actinic porokeratosis: a report of 2 cases on the face. Ann Dermatol. 2011;23(Suppl. 2):S211–3. doi:10.5021/ad.2011.23.S2.S211.

    Article  PubMed  PubMed Central  Google Scholar 

  73. McCullough TL, Lesher JL Jr. Porokeratosis of Mibelli: rapid recurrence of a large lesion after carbon dioxide laser treatment. Pediatr Dermatol. 1994;11(3):267–70.

    Article  CAS  PubMed  Google Scholar 

  74. Itoh M, Nakagawa H. Successful treatment of disseminated superficial actinic porokeratosis with Q-switched ruby laser. J Dermatol. 2007;34(12):816–20. doi:10.1111/j.1346-8138.2007.00392.x.

    Article  PubMed  Google Scholar 

  75. Lee DK, Oh SH, Chang SE, et al. A rare variant of porokeratosis: porokeratosis ptychotropica. J Am Acad Dermatol. 2006;55(5 Suppl.):S120–2. doi:10.1016/j.jaad.2005.12.009.

    Article  PubMed  Google Scholar 

  76. Liu Y, Wang Y, Nie X, et al. Treatment of classic porokeratosis of Mibelli with Q-switched ruby laser. Eur J Dermatol. 2012;22(1):125–6. doi:10.1684/ejd.2011.1552.

    PubMed  Google Scholar 

  77. Lolis MS, Marmur ES. Treatment of disseminated superficial actinic porokeratosis (DSAP) with the Q-switched ruby laser. J Cosmet Laser Ther. 2008;10(2):124–7. doi:10.1080/14764170802068971.

    Article  PubMed  Google Scholar 

  78. Rosenblum J, Roenigk HH Jr. Erbium laser for the treatment of disseminated superficial actinic porokeratosis: a case report. Dermatol Surg. 2013;39(10):1543–5. doi:10.1111/dsu.12261.

    CAS  PubMed  Google Scholar 

  79. Liu HT. Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis (DSP) with frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg. 2000;26(10):958–62.

    Article  CAS  PubMed  Google Scholar 

  80. Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Fractional photothermolysis: a novel treatment for disseminated superficial actinic porokeratosis. Arch Dermatol. 2007;143(11):1450–2. doi:10.1001/archderm.143.11.1450.

    Article  PubMed  Google Scholar 

  81. Alster TS, Nanni CA. Successful treatment of porokeratosis with 585 nm pulsed dye laser irradiation. Cutis. 1999;63(5):265–6.

    CAS  PubMed  Google Scholar 

  82. Ricci C, Rosset A, Panizzon RG. Bullous and pruritic variant of disseminated superficial actinic porokeratosis: successful treatment with grenz rays. Dermatology. 1999;199(4):328–31. doi:10.1159/000018284.

    Article  CAS  PubMed  Google Scholar 

  83. Wolf P. Photodynamic therapy in dermatology: state of the art. J Eur Acad Dermatol Venereol. 2001;15(6):508–9.

    Article  CAS  PubMed  Google Scholar 

  84. Fernandez-Guarino M, Harto A, Perez-Garcia B, et al. Photodynamic therapy in disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol. 2009;23(2):176–7. doi:10.1111/j.1468-3083.2008.02753.x.

    Article  CAS  PubMed  Google Scholar 

  85. Cavicchini S, Tourlaki A. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapy. J Dermatol Treat. 2006;17(3):190–1. doi:10.1080/09546630600788869.

    Article  Google Scholar 

  86. Calzavara-Pinton PG, Rossi MT, Italian Group For Photodynamic T, et al. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications. Photochem Photobiol Sci. 2013;12(1):148–57. doi:10.1039/c2pp25124h.

    Article  CAS  PubMed  Google Scholar 

  87. Gutierrez Paredes E, Bella Navarro R, Montesinos Villaescusa E, Jorda Cuevas E. Porokeratosis of Mibelli: a new indication for photodynamic therapy? Actas Dermosifiliogr. 2013;104(3):259–61. doi:10.1016/j.ad.2012.04.016.

    Article  CAS  PubMed  Google Scholar 

  88. Giuliodori K, Campanati A, Ganzetti G, et al. The successful off-label use of photodynamic therapy for classic porokeratosis of Mibelli: case report. Dermatol Ther. 2011;24(5):501–4. doi:10.1111/j.1529-8019.2012.01473.x.

    Article  PubMed  Google Scholar 

  89. Curkova AK, Hegyi J, Kozub P, et al. A case of linear porokeratosis treated with photodynamic therapy with confocal microscopy surveillance. Dermatol Ther. 2014;27(3):144–7. doi:10.1111/dth.12097.

    Article  PubMed  Google Scholar 

  90. Garcia-Navarro X, Garces JR, Baselga E, Alomar A. Linear porokeratosis: excellent response to photodynamic therapy. Arch Dermatol. 2009;145(5):526–7. doi:10.1001/archdermatol.2009.45.

    Article  PubMed  Google Scholar 

  91. Boiy A, de Witte PA, Roelandts R. Topical treatment of disseminated superficial actinic porokeratosis with hypericin-photodynamic therapy: a case report. Photodiagnosis Photodyn Ther. 2010;7(2):123–5. doi:10.1016/j.pdpdt.2010.02.003.

    Article  CAS  PubMed  Google Scholar 

  92. Garrido-Colmenero C, Ruiz-Villaverde R, Martinez-Garcia E, et al. Photoletter to the editor: response of linear porokeratosis to photodynamic therapy in an 11-year-old girl. J Dermatol Case Rep. 2015;9(4):118–9. doi:10.3315/jdcr.2015.1220.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Nayeemuddin FA, Wong M, Yell J, Rhodes LE. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol. 2002;27(8):703–6.

    Article  CAS  PubMed  Google Scholar 

  94. Levitt J, Emer JJ, Emanuel PO. Treatment of porokeratosis of mibelli with combined use of photodynamic therapy and fluorouracil cream. Arch Dermatol. 2010;146(4):371–3. doi:10.1001/archdermatol.2010.28.

    Article  PubMed  Google Scholar 

  95. Salas T, Hernandez-Gil J, Lopez A, et al. Two cases of disseminated superficial actinic porokeratosis treated with daylight-mediated photodynamic therapy. Dermatol Ther. 2016;29(6):484–5. doi:10.1111/dth.12389.

    Article  PubMed  Google Scholar 

  96. Piccolo D, Di Marcantonio D, Crisman G, et al. Unconventional use of intense pulsed light. BioMed Res Int. 2014;2014:618206. doi:10.1155/2014/618206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Spencer JM, Katz BE. Successful treatment of porokeratosis of Mibelli with diamond fraise dermabrasion. Arch Dermatol. 1992;128(9):1187–8.

    Article  CAS  PubMed  Google Scholar 

  98. Cohen PR, Held JL, Katz BE. Linear porokeratosis: successful treatment with diamond fraise dermabrasion. J Am Acad Dermatol. 1990;23(5 Pt 2):975–7.

    Article  CAS  PubMed  Google Scholar 

  99. Alexis AF, Busam K, Myskowski PL. Porokeratosis of Mibelli following bone marrow transplantation. Int J Dermatol. 2006;45(4):361–5. doi:10.1111/j.1365-4632.2006.02509.x.

    Article  PubMed  Google Scholar 

  100. Otani Y, Katagiri K, Takeuchi Y, et al. A case of giant porokeratosis with vestiges of a cornoid lamella. J Dermatol. 2005;32(11):894–8.

    Article  PubMed  Google Scholar 

  101. Scheiba N, Enk A, Proske S, Hartschuh W. Porokeratosis ptychotropica: successful treatment with the dermatome. Dermatol Surg. 2010;36(2):257–60. doi:10.1111/j.1524-4725.2009.01402.x.

    Article  CAS  PubMed  Google Scholar 

  102. Robinson JB, Im DD, Jockle G, Rosenshein NB. Vulvar porokeratosis: case report and review of the literature. Int J Gynecol Pathol. 1999;18(2):169–73.

    Article  CAS  PubMed  Google Scholar 

  103. Yazkan F, Turk BG, Dereli T, Kazandi AC. Porokeratosis of Mibelli induced by topical corticosteroid. J Cutan Pathol. 2006;33(7):516–8. doi:10.1111/j.1600-0560.2006.00464.x.

    Article  PubMed  Google Scholar 

  104. Levell NJ, Bewley AP, Levene GM. Porokeratosis of Mibelli on the penis, scrotum and natal cleft. Clin Exp Dermatol. 1994;19(1):77–8.

    Article  CAS  PubMed  Google Scholar 

  105. Bhushan M, Craven NM, Beck MH, Chalmers RJ. Linear porokeratosis of Mibelli: successful treatment with cryotherapy. Br J Dermatol. 1999;141(2):389.

    Article  CAS  PubMed  Google Scholar 

  106. Vergara G, Banuls J, Botella R, et al. Porokeratosis of the lower lip. Eur J Dermatol. 2002;12(5):500–2.

    PubMed  Google Scholar 

  107. Goncalves SV, Valente NY, Oliveira Jrunior JV, Paiva DL. Case for diagnosis. An Braz Dermatol. 2012;87(3):489–90.

    Article  Google Scholar 

  108. Dereli T, Ozyurt S, Ozturk G. Porokeratosis of Mibelli: successful treatment with cryosurgery. J Dermatol. 2004;31(3):223–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are indebted to Melanie Peckruhn for providing the dermatopathological photograph.

Author information

Authors and Affiliations

  1. Department of Dermatology, University Hospital Jena, Erfurter Straße 35, 07743, Jena, Germany

    Till Weidner, Tanja Illing, Diana Miguel & Peter Elsner

Authors
  1. Till Weidner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tanja Illing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diana Miguel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Elsner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Till Weidner.

Ethics declarations

Funding

No sources of funding were received for the preparation of this article.

Conflict of interest

T Weidner, T. Illing, D. Miguel, and P. Elsner have no conflicts of interest directly relevant to the content of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weidner, T., Illing, T., Miguel, D. et al. Treatment of Porokeratosis: A Systematic Review. Am J Clin Dermatol 18, 435–449 (2017). https://doi.org/10.1007/s40257-017-0271-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-017-0271-3

Keywords

Search

Navigation